文献速递头颈技术与安全PETMR

FDG PET与MRI测量的肿瘤内异质性与头颈部鳞状细胞癌肿瘤-间质比及临床结局相关

Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.
PubMed 文献 · Clin Radiol · 2017-03-09

研究纳入44例头颈部鳞状细胞癌患者,提取原发肿瘤的FDG PET纹理参数并计算MRI的ADC差值(ADCdiff),评估其与肿瘤-间质比及无复发生存(RFS)的关系。PET粗糙度(r=-0.382)和MRI ADCdiff(r=0.534)与间质比例显著相关;2年RFS预测的最佳影像生物标志物为粗糙度(AUC=0.741)和ADCdiff(AUC=0.779)。多因素分析显示粗糙度(HR=10.549,95%CI 2.544-43.748,p=0.001)是RFS的独立预后因素。

要点

  • PET粗糙度与肿瘤间质比例呈负相关(r=-0.382),MRI ADCdiff与间质比例呈正相关(r=0.534)。
  • 预测2年无复发生存的最佳影像指标为PET粗糙度(AUC=0.741)和MRI ADCdiff(AUC=0.779)。
  • PET粗糙度是RFS的独立预后因素(HR=10.549,95%CI 2.544-43.748,p=0.001)。

核心结论

  • 异质性影像参数与肿瘤-间质比显著相关,这些影像生物标志物可能有助于头颈部鳞状细胞癌的肿瘤复发风险分层。

研究设计与样本

  • 研究纳入44例头颈部鳞状细胞癌患者,提取原发肿瘤的FDG PET纹理参数,并在MRI上计算最小与最大表观扩散系数之差(ADCdiff),评估其与肿瘤-间质比及无复发生存的关系。

诊断标准与关键数值

  • PET粗糙度与间质比例显著相关(r=-0.382)。
  • MRI ADCdiff与间质比例显著相关(r=0.534)。
  • 预测2年无复发生存:PET粗糙度AUC=0.741,MRI ADCdiff AUC=0.779。
  • 多因素分析:PET粗糙度是RFS的独立预后因素(HR=10.549,95%CI 2.544-43.748,p=0.001)。

临床应用与阅片要点

  • 作者认为异质性影像参数与肿瘤-间质比显著相关,这些影像生物标志物可能有助于头颈部鳞状细胞癌的复发风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the association between the tumour-stroma ratio and intratumoural heterogeneity measured using 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET) and magnetic resonance imaging (MRI), and further investigate the prognostic significance of imaging biomarkers in head and neck squamous cell carcinoma (HNSCC).

MATERIALS AND METHODS: Textural-based imaging parameters of the primary tumour were extracted in 44 patients. In addition, the difference between the minimum and maximum apparent diffusion coefficient (ADC) values (ADCdiff) was calculated on MRI. The relationships between the tumour-stroma ratio and imaging parameters were evaluated. The associations between imaging parameters and recurrence-free survival (RFS) were assessed using Cox proportional hazard regression models.

RESULTS: Coarseness (r=-0.382) on PET and ADCdiff (r=0.534) on MRI were significantly correlated with the proportion of stroma. The best imaging biomarkers for the 2-year RFS prediction were coarseness (AUC=0.741) and ADCdiff (AUC=0.779). Multivariate analysis showed that coarseness (hazard ratio=10.549, 95% confidence interval=2.544-43.748, p=0.001) was an independent prognostic factor for RFS.

CONCLUSION: Heterogeneity imaging parameters are significantly associated with the tumour-stroma ratio. These imaging biomarkers may help to facilitate the risk stratification for tumour recurrence in HNSCC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Choi JW, Lee D, Hyun SH, et al. Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma. Clin Radiol. 2017. PMID: 28285707. doi:10.1016/j.crad.2017.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。